Citation only
via Europe PMC
Biomarker profiles in late-life depression and Alzheimer's disease across and beyond the A/T/N framework: A scoping review.
Zhu Y, Damera N, Singh RK, Bekena S, Kelble L, McGuire K, Hu Y, Mersiehazen E, Vijay G, Nazif A, Kolady R, Xiang L, Liu X, Flores S, Dombrowski K
Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
Abstract
Depression and Alzheimer's disease (AD) frequently overlap clinically, and depressive symptoms may signal major depressive disorder, a risk factor for AD, or an early manifestation of neurodegeneration. This scoping review mapped biomarker evidence differentiating depression and AD within and beyond the amyloid/tau/neurodegeneration (A/T/N) framework. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines, MEDLINE, Embase, and Scopus were searched for studies published between 2010 and 2025 examining biomarkers in depression and AD. Eligible studies included clinical diagnoses of AD and/or depression and reported biomarker measures. Forty-eight studies met inclusion criteria. Amyloid biomarkers were most consistently associated with clinically diagnosed AD, whereas findings for other biomarkers were more heterogeneous. Neurodegeneration markers, including hippocampal atrophy, were commonly associated with AD, while vascular abnormalities and altered functional connectivity were more frequently linked to depressive symptoms. Overall, AD and depression demonstrated partially distinct but overlapping biomarker profiles, highlighting the need for longitudinal studies using scalable biomarkers to clarify causal and temporal relationships.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1002/alz.71739
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Y, Z., N, D., RK, S., S, B., L, K., K, M., Y, H., E, M., G, V., A, N., R, K., L, X., X, L., S, F., K, D., S, P., A, H., K, T., JF, T., & BM, A. (2026). Biomarker profiles in late-life depression and Alzheimer's disease across and beyond the A/T/N framework: A scoping review. <em>Alzheimer's & dementia : the journal of the Alzheimer's Association</em>. https://doi.org/10.1002/alz.71739
Vancouver
Y Z, N D, RK S, S B, L K, K M, et al. Biomarker profiles in late-life depression and Alzheimer's disease across and beyond the A/T/N framework: A scoping review. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2026. doi:10.1002/alz.71739.
BibTeX
@article{zhu2026Biomar,
title = {Biomarker profiles in late-life depression and Alzheimer's disease across and beyond the A/T/N framework: A scoping review.},
author = {Zhu Y and Damera N and Singh RK and Bekena S and Kelble L and McGuire K and Hu Y and Mersiehazen E and Vijay G and Nazif A and Kolady R and Xiang L and Liu X and Flores S and Dombrowski K and Pal S and Hardi A and Taylor K and Trani JF and Ances BM and Lenze EJ and Vemuri P and Jack CR and Petersen RC and Babulal GM.},
journal = {Alzheimer's & dementia : the journal of the Alzheimer's Association},
year = {2026},
doi = {10.1002/alz.71739},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Psychiatry International 2026
Open access · CC-BY
Peripheral Inflammatory Biomarkers in First-Episode, Drug-Naïve Major Depressive Disorder: A Systematic Review
Frontiers in aging neuroscience 2026
Citation only
Atherosclerotic cardiovascular disease risk is associated with AT(N)V neuroimaging biomarkers and cognitive impairment in the health and aging brain study-health disparities cohort.
Muscles (Basel, Switzerland) 2026
Open access · OA
Sarcopenia and Vitamin B12: Where Do We Stand?
The Journals of Gerontology Series A 2013
Citation only
Longitudinal Changes in Leukocyte Telomere Length and Mortality in Humans
The Lancet Healthy Longevity 2025
Open access · CC-BY
Biological age measured by DNA methylation clocks and frailty: a systematic review and meta-analysis
Dementia & Neuropsychologia 2016
Open access · CC-BY